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Wei Zhang1, Zhichun Lin2, Tongxian Zhang1, Fen Liu1 and Yun Niu1*Abstract
We report a case of pure invasive cribriform carcinoma of the breast, which had been untreated for thirteen years,
being found with bone metastasis at initial presentation, because distant metastasis is rarely found in this tumor. A
fifty-nine-year-old postmenopausal woman presented with a large left breast mass. Although she had noticed a
lump in a left breast thirteen years ago, she had not sought treatment. The tumor had enlarged gradually since
from one year before and become ulcerated. The two enlarged axillary lymph nodes were also palpable. After two
cycles of neoadjuvant chemotherapy, she underwent left radial mastectomy with a free skin graft. Emission
computed tomography result has confirmed bone metastasis. The histological diagnosis of the tumor revealed the
pure invasive cribriform carcinoma, since over than ninety percent of invasive tumor components showed a
characteristic cribriform growth, and the remainder was tubular carcinoma. She has been well without evidence of
tumor recurrence for seven years after surgery and several routine postoperative therapies. Although with favorable
prognosis, pure invasive cribriform carcinoma is still possible to develop into the advanced (Stage four) breast
cancer if untreated for a long time. However, the survival of this patient for free disease after several locoregional
and systemic therapies maybe provide a supplement for invasive cribriform carcinoma’s excellent prognosis.
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Invasive cribriform carcinoma (ICC) of the breast is
characterized by the predominant cribriform growth pat-
tern of its infiltrating component. The prognosis of ICC
has been reported to be excellent, similar to tubular car-
cinoma (TC), sometimes even approaching or equaling
that of the general population [1-4]. According to the
World Health Organization (WHO) new definition [5],
pure ICC is a type of carcinoma with infiltrating compo-
nents presenting an almost entirely (> 90%) invasive
cribriform pattern. The lesions show a predominantly
cribriform arrangement. The remaining components
limited to TC are also included in the category of ICC.
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reproduction in any medium, provided the orthan TC (< 50%) are regarded as mixed-type ICC. Pure
ICC is very rare and usually associated with smaller
tumor sizes, less lymph node metastasis involvement,
lower tumor stages and better prognosis compared with
mixed ICC [1,5]. In addition, distant metastasis of pure
ICC has rarely been found till now. In this paper, we re-
port an advanced pure ICC case of the breast that had
been left untreated for a considerable amount of time,
with distant metastases (bone).Case presentation
A 59-year-old postmenopausal woman visited our hos-
pital in November 2003 with a large left breast mass.
She had noticed a lump approximately 2.0 cm in size in
the superior external quadrant of the left breast in 1990
but did not consult a doctor. The tumor gradually grew
and became ulcerated in 2002. Physical examination
revealed a large mass (10 cm × 10 cm × 5 cm) in the
whole left breast, with a superficial ulcer of an area of
7 cm × 7.5 cm in the superior external quadrant. An areaLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The image of 99Tcm-methylene diphosphonate (MDP)
bone scintigraphy after left radical mastectomy. The bone scan
showed radioactive concentration in the tenth and eleventh
thoracic vertebrae, indicating the appearance of bone metastasis at
these sites.
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adhered to the tumor, which was fixed to the chest wall.
The left nipple was invaginated and fixed. Two enlarged
lymph nodes (4 cm × 4 cm and 3.5 cm × 3 cm) were
found in the patient’s left axilla; these nodes had fused
together and could not move freely. No mass was palp-
able in the opposite breast or in the bilateral supraclavi-
cular fossa. Mammography excluded a lesion of the
opposite breast. Thoracic computed tomography (CT)
showed that the large tumor occupied the left breast and
enlarged lymph nodes were detected in the left axilla.
Moreover, the image of multiple nodules in both lungs
raised the suspicion of distant lung metastasis but
there was no further evidence to confirm this. Emis-
sion computed tomography (ECT) indicated that the
tenth and eleventh thoracic vertebrae had bone metas-
tases (Figure 1). Abdominal ultrasonography revealed
no metastatic lesions in the abdominal organs.
After two cycles of neoadjuvant chemotherapy (cyclo-
phosphamide, doxorubicin and fluorouracil, CAF), the
volumes of both tumor and axillary lymph nodes
decreased and one of the lymph nodes became impalp-
able. The patient’s red blood cell (RBC) and white blood
cell (WBC) concentrations decreased to 2.44 × 1012/L
and 3.48 × 109/L, respectively. Her hemoglobin concen-
tration also decreased to 66 g/L, possibly due to the side
effects of chemotherapy. The patient received adjuvant
hemopoietic treatment until her WBC reached normal
levels.
The patient then underwent left radical mastectomy
with the aim of cytoreduction. The skin defect after
mastectomy was repaired with a free skin graft from the
abdominal wall. Histological pathology confirmed the
tumor as pure ICC because > 90% of its infiltrating com-
ponents exhibited a characteristic cribriform pattern
(Figure 2). The tumor occupied almost the whole left
breast except for the inferior intermediate quadrant. The
nipple and areola of the left breast were also involved
and tumor cells had infiltrated the skin and muscles
(Figure 3). Of the twenty-five axillary lymph nodes
sampled, the presence of obvious metastasis and micro-
metastasis was found in one lymph node (Figure 4a and
4b); infiltration of paranodal tissue was found in another
lymph node (Figure 4c). Immunohistochemical staining
indicated that 15% of the tumor cells were positive for
estrogen receptor (ER) and progestogen receptor (PR).
Approximately 30% of the tumor cells displayed incom-
plete membranous staining for human epidermal growth
factor receptor 2 (HER2, 1+). Approximately 10% and
20% of the tumor cells showed weak nuclear staining for
Ki67 and p53, respectively.
After surgery, the patient was continuously treated
with intravenous CAF, the dosage of which was decided
based on the square of the patient’s body. Treatmentbegan on postoperative day 1 and continued for two-
week intervals for four cycles. The patient then received
postoperative radiotherapy on the tenth and eleventh
thoracic vertebrae because of the possibility of bone me-
tastasis, taking pamidronate at the same time. The pa-
tient received hormonal therapy afterwards. Tamoxifen
was used for three years after radiotherapy and then
replaced with letrozole for another two years due to the
patient’s inability to tolerate the side effects of tamoxi-
fen. Follow-up was carried out at three-month intervals
Figure 2 Two representative areas show that most infiltrating tumor cells are arranged in groups with a cribriform growth pattern,
with obvious sclerotic stroma between the tumor nests. Scale bars = 5 μm in a and b.
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second year, and every 12 months thereafter. The med-
ical work-up consisted of regular physical checkups, im-
aging tests, such as chest radiograph, bone scan, and/or
ultrasound, and examination for recurrences, second pri-
mary breast cancers, or other metastatic diseases. The
patient remained well without any signs of tumor recur-
rence even seven years after the operation.Figure 3 Tumor cells invade into the skin and muscle. (a) Numerous cr
cells even infiltrate into the epidermis. Magnified views of box 1 and box 2
the epidermis have grown in a cribriform pattern. (c) The invasive cribriform
cribriform growth. (d) Some tumor cells invade the muscle. A magnified vi
usually display in a cribriform pattern. Scale bars = 5 μm in a and d, 10 μmDiscussion
ICC is a rare invasive breast carcinoma with an excellent
prognosis. The incidence of ICC was reported to range
from 0.3% to 3.5% [1,6-8]. While the WHO earlier defin-
ition (2003) and Page’s description classified ICC into
classical and mixed subtypes [1,9], the WHO new edi-
tion (2012) seems to weaken the concept of the classical
ICC [5]. In any case, both the old and new WHOibriform carcinoma cells present in the dermis of skin. Some tumor
are displayed in (b) and (c), respectively. (b) The tumor cells invading
carcinoma may be the origin of ductal carcinoma in situ, often in a
ew is shown in the boxed area d1. The infiltrating carcinoma cells
in b and c, and 20 μm in d1.
Figure 4 The histology of axillary lymph node metastasis in the patient. (a) The obvious metastasis is detected in one lymph node and the
infiltrating tumors cells appear in a cribriform pattern. (b) A micro-metastasis is detected in one lymph node. A magnified view is shown in the
boxed area b1; it shows the micro-metastatic cells in a cribriform growth pattern. (c) One lymph node indicates the infiltration of paranodal
tissue. A magnified view is shown in the boxed area c1, also showing the invasive cells in a cribriform style. Scale bars = 2.5 μm in a-c, 20 μm
in b1 and c1.
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breast carcinoma with infiltrating components present-
ing an almost entirely (>90%) invasive cribriform pat-
tern. Venable [6] reported 62 cases of ICC from 1,087
patients with primary breast carcinoma and found a
five-year survival rate of 93.1% for all ICC cases (all died
of ICC with < 50% invasive cribiform pattern), and 100%
survival for ICC with 50% to 99% invasive cribiform pat-
tern (including pure ICC). Page et al. [1] reported 51
cases of ICC (35 classical and 16 mixed ICC) over an
average follow-up time of 12.5 years. They found 10-year
survival rates of 97% for classical ICC and 50% for mixed
ICC. One patient with classical ICC died from a second
and contralateral carcinoma, not the primary ICC. Ellis
et al. [7] compared 10-year survival rates for different
histological types in 1,621 cases of primary breast can-
cer. Ductal carcinoma in situ, cribriform and TC had ex-
cellent prognoses, with 10-year survival rates of 92%,
91% and 90%, respectively, compared with 80% for mu-
cinous carcinoma, 51% for medullary carcinoma, 54%
for lobular carcinoma and 47% for invasive ductal
carcinoma-not other specified (IDC-NOS). The fre-
quency of metastasis in the axillary lymph nodes was
lower in pure ICC than in mixed ICC (14.3% vs. 25%, re-
spectively) [1]. Venable found that the maximal number
of positive lymph nodes in pure ICC was three [6]. To
date, evidence of distant metastasis in ICC have been
limited, especially for pure ICC.
In this paper, we report a case of pure ICC with bone
matastasis that had been left untreated for 13 years. The
patient’s pathology revealed that over 90% of the invasive
tumor cells grew in a cribriform pattern, thus, the patient
was considered to have pure ICC. The tumor cells that
had locally invaded the nipple, skin and muscle were still
arranged in a cribriform pattern (as indicated by Figure 3).
Histology verified only one obvious metastatic lymph
node and one micro-infiltrating lymph node, possibly dueto the effect of two cycles of neoadjuvant chemotherapy
received by the patient. Although we detected multiple
nodules in both lungs during CT imaging on initial exam-
ination, we could not ascertain whether or not the patient
had lung metastasis because she did not show any pul-
monary symptoms at her first diagnosis and subsequent
follow-up. Surprisingly, the patient was alive seven years
after neoadjuvant chemotherapy, radical mastectomy, and
postoperative systemic therapy. Taking the 13 years prior
to treatment into account, this patient had survived for at
least 20 years after the discovery of the lump in her breast.
Page [1] first reported that the average age of classical
ICC is 53 years, younger than the age in mixed ICC
(63 years). Venable reported that the mean age of patients
with ICC is 58 years, including individuals whose tumors
contain a cribriform pattern in less than 50% of cells [6].
Although the age at diagnosis of the patient in the present
case was 59 years, her actual age during discovery of the
lump was 46 years, younger than in the Page and Venable
reports. Our recent retrospective investigation of 51 ICC
cases found that the average age of patients with pure ICC
was 51 years (unpublished data). We thus speculate that
the different ages at diagnosis may contribute to this dif-
ference because breast carcinomas may now be detected
earlier with the use of more advanced detection techni-
ques and increased awareness of self-examination. Second,
ethnic differences might result in this disparity, which was
confirmed by recent publications on IDC-NOS [10-12].
The ICC tumor may present as a mass but is frequently
clinically occult, and may escape radiological detection.
Thus, lesions are usually larger at presentation, although
they grow slowly over time [7].
The patient in this case noted a lump with a diameter
of 2.0 cm 13 years ago but did not consult a doctor. The
tumor finally grew to a large mass with a diameter of
10 cm. The nipple, skin, and muscle were also involved.
The patient’s pathology revealed well-differentiated
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regular islands with extensive gland lumen formation.
Cytologically, the nuclear grade is usually low or moder-
ate, and the karyokinesis is rare. The remaining compo-
nents of this tumor (< 10%) comprised TC, which has
been confirmed to be occasionally associated with ICC
(23%) [6]. Taylor and Norris [13] speculated that TC
may, in some instances, serve as a differentiation bridge
between intraductal carcinoma and ICC. Previous stud-
ies have indicated that in ICC there is expression of ER,
but mostly there is expression of PR (69%), which could
contribute to the favorable prognosis of this breast car-
cinoma [1,5,6]. ER and PR in this pure ICC case were
found in 15% of the tumor cells even after 13 years of
disease development. We thus speculate that the persist-
ent expression of hormone receptors in pure ICC is a
factor that influences the excellent prognosis of the car-
cinoma, given that the tumor at initial mass was positive
for ER, since no publications of negative ER for pure
ICC have been reported to date [1,5,6]. Previous publica-
tions [1,5-7] indicated that only metastatic lymph nodes
in pure ICC are arranged in a cribriform pattern, similar
to primary ICC tumors; such findings were confirmed
by our results. Tumor cells in one micro-infiltrating
lymph node and in other paranodal tissues also dis-
played a similar morphology (Figure 4b and 4c).
To date, the prognostic significance of the clinicopatho-
logical characteristics of ICC patients has not yet to be
well established because of the low incidence rate and lack
of a standard definition for the carcinoma. Thus, treat-
ment guidelines for ICC are mostly extrapolated from data
based on IDC without clear validation. The case we
reported was a late-stage (T4) breast carcinoma for which
comprehensive therapy was carried out. Neoadjuvant
chemotherapy was performed because of the large size of
the mass and the presence of two enlarged axillary lymph
nodes. Radical corrective surgery for cytoreduction and
endocrine therapy followed., Thoracic radiotherapy was
also performed because of the possibility of bone metasta-
sis. Several recent publications have questioned whether
adjuvant chemotherapy is suitable in ICC cases, because
reports on the efficacy of adjuvant or neoadjuvant chemo-
therapy in patients with ER-positive disease are limited
[14-16]. Colleoni [4] recommended no therapy or endo-
crine therapy alone for favorable histotypes (such as, tubu-
lar, cribriform, mucinous, papillary) with luminal tumors.
Caution must be exercised when making such a decision.
Neoadjuvant chemotherapy was partially effective for this
patient because of the shrink in both the tumor and axil-
lary lymph node. However, we cannot exclude the roles
that postoperative local and systemic therapies played in
the patient’s excellent prognosis. We believe that defin-
ition of specific niches for tailored research through inter-
national cooperation and prospective investigations of thistopic are necessary to make progress and achieve a
consensus on the treatment of individual patients with
ICC.
Conclusions
Pure ICC is a rare and special histological form of breast
cancer with excellent prognosis. At present, distant me-
tastasis of pure ICC has rarely been reported inside or
outside of the country. The current study presents a
large left breast mass that had been untreated for
13 years and exhibited axillary lymph node and bone
metastases. This mass was histologically verified to be
pure ICC. Such a progression is not an ordinary devel-
opment for pure ICC and surgeons should be aware that
pure ICC may develop into advanced breast cancer
when left untreated for a long period of time. The sur-
vival of the patient discussed in this study after several
routine therapies indicates the excellent prognosis for
pure ICC.
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